Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance

BACKGROUND: The use of quinolone prophylaxis in high-risk neutropenic patients is considered standard of care but the development of resistance is a concern. Previous studies have focused mainly on quinolone resistance among patients receiving prophylaxis, with very few data reporting its impact on...

Descripción completa

Detalles Bibliográficos
Autores principales: Garnica, Marcia, Nouér, Simone A, Pellegrino, Flávia LPC, Moreira, Beatriz M, Maiolino, Angelo, Nucci, Marcio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729823/
https://www.ncbi.nlm.nih.gov/pubmed/23899356
http://dx.doi.org/10.1186/1471-2334-13-356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729823/
https://www.ncbi.nlm.nih.gov/pubmed/23899356
http://dx.doi.org/10.1186/1471-2334-13-356

Ejemplares similares